IL17A and osteoporosis: Future efforts must prioritize the development of targeted immunomodulatory strategies, such as neutralizing specific cytokines (e.g., IL-17), reprogramming macrophage polarization, or restoring protective lymphocyte subsets, to pave the way for novel and precise therapeutic interventions in osteoporosis.